These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17298106)

  • 1. Survey of safety and efficacy information in drug inserts for topical prescription medications.
    Zaghi D; Maibach HI
    Am J Clin Dermatol; 2007; 8(1):43-6. PubMed ID: 17298106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.
    Fed Regist; 1982 Sep; 47(173):39249-50. PubMed ID: 10258155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 4. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
    Davis JJ
    J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
    Gruber MF
    Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial.
    McCormack L; Craig Lefebvre R; Bann C; Taylor O; Rausch P
    Drug Saf; 2016 Feb; 39(2):171-84. PubMed ID: 26547718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.
    Gebran N; Al Haidari K
    Ann Saudi Med; 2006; 26(3):192-9. PubMed ID: 16861873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
    Brucker MC; King TL
    J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
    Marroum PJ; Gobburu J
    Clin Pharmacokinet; 2002; 41(3):161-9. PubMed ID: 11929317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse-drug-event data provided by pharmaceutical companies.
    Cudny ME; Graham AS
    Am J Health Syst Pharm; 2008 Jun; 65(11):1071-5. PubMed ID: 18499882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
    Pai SA; Kshirsagar N
    J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.